Eric Wayne Golightly

Array ( [id] => 1507025 [patent_doc_number] => 06440701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Transferrin receptor genes of Moraxella' [patent_app_type] => B1 [patent_app_number] => 09/059584 [patent_app_country] => US [patent_app_date] => 1998-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 172 [patent_figures_cnt] => 172 [patent_no_of_words] => 45559 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440701.pdf [firstpage_image] =>[orig_patent_app_number] => 09059584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446377 [patent_doc_number] => 06368812 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Process for determining the agonist or antagonist of galanin receptor (GALR3)' [patent_app_type] => B1 [patent_app_number] => 09/058333 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 47338 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368812.pdf [firstpage_image] =>[orig_patent_app_number] => 09058333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095755 [patent_doc_number] => 20020052018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'INWARD RECTIFIER, G-PROTEIN ACTIVATED, MAMMALIAN, POTASSIUM CHANNELS AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/039927 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10863 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052018.pdf [firstpage_image] =>[orig_patent_app_number] => 09039927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630298 [patent_doc_number] => 07132258 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Nucleic acid encoding vitamin D receptor related polypeptide' [patent_app_type] => utility [patent_app_number] => 09/041994 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33650 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132258.pdf [firstpage_image] =>[orig_patent_app_number] => 09041994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4420188 [patent_doc_number] => 06194547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'ETS2 repressor factor (ERF)' [patent_app_type] => 1 [patent_app_number] => 9/021715 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 33 [patent_no_of_words] => 22448 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194547.pdf [firstpage_image] =>[orig_patent_app_number] => 021715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1592750 [patent_doc_number] => 06383483 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Staphylokinase derivatives with cysteine substitutions' [patent_app_type] => B1 [patent_app_number] => 09/020018 [patent_app_country] => US [patent_app_date] => 1998-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25938 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383483.pdf [firstpage_image] =>[orig_patent_app_number] => 09020018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508393 [patent_doc_number] => 06441133 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Thyrotropin-releasing hormone receptor 2(TRHR-2)' [patent_app_type] => B1 [patent_app_number] => 09/029027 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9602 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441133.pdf [firstpage_image] =>[orig_patent_app_number] => 09029027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527857 [patent_doc_number] => 06479253 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Serine protease inhibitor nucleic acid molecules and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/005352 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38356 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479253.pdf [firstpage_image] =>[orig_patent_app_number] => 09005352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1484895 [patent_doc_number] => 06365392 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Filariid nematode cysteine protease nucleic acid molecules and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/005298 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34735 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365392.pdf [firstpage_image] =>[orig_patent_app_number] => 09005298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507726 [patent_doc_number] => 06440928 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Method for treating diabetic neuropathy with NGF' [patent_app_type] => B1 [patent_app_number] => 09/004965 [patent_app_country] => US [patent_app_date] => 1998-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 17684 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440928.pdf [firstpage_image] =>[orig_patent_app_number] => 09004965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367773 [patent_doc_number] => 06287855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Nucleic acid encoding rat galanin receptor (GALR2)' [patent_app_type] => 1 [patent_app_number] => 8/993088 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 13245 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287855.pdf [firstpage_image] =>[orig_patent_app_number] => 993088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535880 [patent_doc_number] => 06337206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Nucleic acid encoding mouse galanin receptor (GALR2)' [patent_app_type] => B1 [patent_app_number] => 08/993424 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 11703 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337206.pdf [firstpage_image] =>[orig_patent_app_number] => 08993424 [rel_patent_id] =>[rel_patent_doc_number] =>)